Helius Med Technolog (HSDT) 0.9980 $HSDT Helius Medical

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Helius Med Technolog (HSDT) 0.9980 $HSDT

Helius Medical Technologies Announces That Registration Statement on Form S-1 has Been Declared Effective
Marketwired - Wed Jul 13, 8:04AM CDT
NEWTOWN, PENNSYLVANIA--(Marketwired - Jul 13, 2016) - Helius Medical Technologies, Inc. (TSX:HSM)(OTCQB:HSDT) ("Helius" or the "Company" announced today that the Securities and Exchange Commission ("SEC" has declared effective the Company's registration statement on Form S-1 relating to the resale of up to 11,953,115 shares of the Company's Class A common stock, without par value (the "Common Shares), 5,074,560 warrants to purchase shares of the Company's Class A common stock at an exercise price of CAD$1.50 per share (US$1.15 per share at the noon exchange rate as published by the Bank of Canada on July 12, 2016) (the "Warrants", and 5,074,560 shares of our Class A common stock issuable upon the exercise of the Warrants held by certain securityholders of the Company named in the registration statement (the "Warrant Shares", and together with the Common Shares and the Warrants, the "Securities".
HSM.TO: 1.28 (-0.03)

Helius Medical Announces Results from a Case Series of Subjects With Advanced MS
Marketwire Canada - Tue Jun 21, 8:03AM CDT
NEWTOWN, PENNSYLVANIA--(Marketwired - Jun 21, 2016) - Helius Medical Technologies, Inc. (TSX:HSM)(TSX:HSM.S)(OTCQB:HSDT) ("Helius" or the "Company" is pleased to announce the results of a case series of individuals with advanced symptoms of Multiple Sclerosis (MS) treated with PoNS™ Therapy.
HSM.TO: 1.28 (-0.03), HSM-S.TO: 1.18 (-0.21)

Helius Medical Announces Proceeds of $1.4 Million From Exercise of Warrants
Marketwired - Mon Jun 06, 8:03AM CDT
NEWTOWN, PENNSYLVANIA--(Marketwired - Jun 6, 2016) - Helius Medical Technologies, Inc. (TSX:HSM)(OTCQB:HSDT) ("Helius" or the "Company" a medical technology company focused on the treatment of neurological symptoms caused by disease or trauma, is pleased to announce that it received proceeds of CDN $1,825,600 (approximately US$1,409,947) from the exercise of certain warrants issued in 2014, all of which was received after the Company's fiscal year end on March 31, 2016.
HSM.TO: 1.28 (-0.03)

Helius Medical Technologies Restates and Re-Files Historical Financial Statements for Non-Cash Reclassification of Warrants
Marketwired - Tue Apr 26, 4:06PM CDT
Helius Medical Technologies, Inc. (TSX: HSM)(OTCQB: HSDT) ("Helius" or the "Company" - The Company is issuing the following press release to clarify its disclosure.
HSM.TO: 1.28 (-0.03)

CSE: 2016-0408 - Delist - Helius Medical Technologies Inc. (HSM)
Marketwired - Mon Apr 18, 10:30AM CDT
The common shares of Helius Medical Technologies Inc. will be delisted at the market close today, April 18, 2016.

IIROC Trade Resumption - Helius Medical Technologies, Inc.
Newsfile Corp - Mon Apr 18, 8:25AM CDT
Trading resumes in:

IIROC Trade Resumption - HSM.S
CNW Group - Mon Apr 18, 8:24AM CDT
Trading resumes in:

IIROC Trade Halt - Helius Medical Technologies, Inc. Reg S Shares
Newsfile Corp - Mon Apr 18, 7:27AM CDT
The following issues have been halted by IIROC:

Helius Medical Technologies Restates and Re-files Historical Financial Statements
TheNewswire.ca - Mon Jan 11, 7:30AM CST
(via Thenewswire.ca)

Helius Medical Technologies Announces Allowances of 10 New Patents
BusinessWire - Mon Jan 04, 4:43PM CST
Helius Medical Technologies, Inc. (CSE:HSM; OTCQB:HSDT) ("Helius", or the "Company", a medical technology company focused on the treatment of neurological symptoms caused by disease or trauma, announced today that ten (10) new patent applications (seven US and three Chinese) have been allowed by the US and Chinese Patent Offices in November and December 2015 building on the already strong patent portfolio of the company. The Company has a further 33 patents (22 US and 11 international) pending on its technology in the US and other markets around the world.

Helius Medical Technologies Announces Receipt of Remainder of A&B Funding, Changes to Board of Directors, and Extension of CRADA Agreement Through December 2017
BusinessWire - Thu Dec 31, 5:03PM CST
Helius Medical Technologies, Inc. (CSE:HSM; OTCQB:HSDT) ("Helius", or the "Company", a medical technology company focused on the treatment of neurological symptoms caused by disease or trauma, today announced that the Company has elected to draw down on the remaining USD $5 million credit facility from A&B (HK) Company Limited ("A&B", appointed two new members to its Board of Directors and obtained an extension to its Cooperative Research and Development Agreement ("CRADA" with the US Army Medical Research and Material Command ("USAMRMC".

Helius Medical Technologies Announces Positive Clinical Trial Results from its Multiple Sclerosis Pilot Study
BusinessWire - Mon Nov 02, 8:23AM CST
Helius Medical Technologies, Inc. (CSE: HSM; OTCQB: HSDT) ("Helius", or the "Company", a medical technology company focused on the treatment of neurological symptoms caused by disease or trauma, announced today that the Multiple Sclerosis ("MS" pilot study evaluating its investigational Portable Neuromodulation Stimulator ("PoNS(TM)" device, met all of its study objectives. A total of 14 subjects (7-active and 7-sham control) received treatment with the non-invasive brain stimulation technology and concomitant physiotherapy. The independent trial took place at the Montreal Neurological Institute and Hospital and Concordia University's PERFORM Center. The study objectives were to explore the potential beneficial effects of PoNS(TM) stimulation, as previously reported, and to provide data to be used for the design of future studies to support requests for marketing authorization. The study included the first use of Functional MRI ("fMRI" to measure the effect of PoNS(TM) while performing tasks with, and without, stimulation.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 124

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 7

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 415

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 324

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 136

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 77

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 42

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 44

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 258

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation into Inspire Medical Systems: What Investors Need to Know

Updated Category News Views 166

Investigation of Inspire Medical Systems and Shareholder Rights Faruqi & Faruqi, LLP, a prominent player in the field of securities law, is taking proactive steps to investigate potential claims regarding Inspire Medical Systems, Inc. This company has garnered attention recently due to its significant developments and ongoing operations. Investors who have experienced...

Continue Reading
Ecopro BM Faces Downgrade Amidst Battery Industry Challenges

Updated Category News Views 71

Market Response to Ecopro BM's Stock Downgrade Recently, Ecopro BM Co Ltd (247540:KS) faced a significant shift in its market perception as Nomura/Instinet downgraded the company's stock rating from Buy to Neutral. This adjustment comes with a newly revised price target focused on KRW240,000, a notable decrease from the previous KRW290,000. The decision is primarily...

Continue Reading
Exploring the Current State of Sea's Options Trading Landscape

Updated Category News Views 163

Exploring the Current State of Sea's Options Trading Landscape Recent market movements surrounding Sea (NYSE: SE) have sparked considerable interest among investors and traders alike. A comprehensive analysis of the options trading history for Sea reveals notable bearish activity. In our investigation, we identified 16 unusual trades that reflect a cautious outlook among...

Continue Reading
Empowering Women in Whiskey: The Rise of Lythgoe Bourbon

Updated Category News Views 94

Celebrating Women in the Whiskey Industry with Lythgoe Bourbon In a male-dominated field, one entrepreneur is making waves by honoring women in whiskey. The story of Lythgoe Bourbon begins with Dina Coker, who recognized a remarkable trend in the bourbon market. Despite the traditional narrative focused on male brands and locations in Kentucky, women are a significant...

Continue Reading
Waste Connections Declares Quarterly Cash Dividend for Investors

Updated Category News Views 110

Waste Connections Announces Regular Quarterly Cash Dividend Waste Connections, Inc. (TSX/NYSE: WCN) is making strides in providing returns for its shareholders by declaring a regular quarterly cash dividend of $0.315 U.S. per common share. This decision was made by the Company's Board of Directors and reflects their commitment to offering consistent shareholder value. The...

Continue Reading